• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡氏肺孢子虫肺炎合并获得性免疫缺陷综合征患者早期致命结局及长期生存的预后因素

Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

作者信息

Antinori A, Maiuro G, Pallavicini F, Valente F, Ventura G, Marasca G, Murri R, Pizzigallo E, Camilli G, Tamburrini E

机构信息

Clinica delle Malattie Infettive, Università Cattolica S. Cuore, Roma, Italy.

出版信息

Eur J Epidemiol. 1993 Mar;9(2):183-9. doi: 10.1007/BF00158789.

DOI:10.1007/BF00158789
PMID:8100199
Abstract

Fifty-five episodes of Pneumocystis carinii pneumonia (PCP) in AIDS patients were evaluated to assess clinical and laboratory risk factors predicting the probability of surviving the acute episode of PCP and the long-term survival after PCP. Age > 45 yrs, PaO2 < 50 mmHg, AaPO2 > 50 mmHg, and LDH > 800 IU/L correlated strongly with early mortality; patients who needed mechanical ventilation had a significantly lower PaO2 and serum albumin, and higher AaPO2 and LDH compared to the patients who did not. Neither age nor PaO2, AaPO2, LDH, albumin, days from onset, time for recovery, CD4+ cell count correlated with long-term survival of AIDS patients with PCP. Informations obtained at initial presentation of PCP may predict early outcome and influence therapeutic approach, improving chances for survival.

摘要

对55例艾滋病患者的卡氏肺孢子虫肺炎(PCP)发作情况进行了评估,以评估预测PCP急性发作存活概率及PCP后长期生存的临床和实验室危险因素。年龄>45岁、动脉血氧分压(PaO2)<50 mmHg、肺泡-动脉血氧分压差(AaPO2)>50 mmHg和乳酸脱氢酶(LDH)>800 IU/L与早期死亡率密切相关;与不需要机械通气的患者相比,需要机械通气的患者PaO2和血清白蛋白显著降低,AaPO2和LDH更高。年龄、PaO2、AaPO2、LDH、白蛋白、起病天数、恢复时间、CD4+细胞计数均与PCP艾滋病患者的长期生存无关。PCP初次出现时获得的信息可预测早期预后并影响治疗方法,从而提高生存机会。

相似文献

1
Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.卡氏肺孢子虫肺炎合并获得性免疫缺陷综合征患者早期致命结局及长期生存的预后因素
Eur J Epidemiol. 1993 Mar;9(2):183-9. doi: 10.1007/BF00158789.
2
Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Is the prognosis really improved?获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎的机械通气治疗。预后真的得到改善了吗?
Chest. 1993 Sep;104(3):756-62. doi: 10.1378/chest.104.3.756.
3
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.接受齐多夫定治疗的晚期人类免疫缺陷病毒感染患者的肺孢子菌预防与生存情况。齐多夫定流行病学研究组。
Arch Intern Med. 1992 Oct;152(10):2009-13.
4
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.影响艾滋病患者卡氏肺孢子虫肺炎预后的因素
Thorax. 1995 Jun;50(6):668-71. doi: 10.1136/thx.50.6.668.
5
Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
Arch Intern Med. 1992 Dec;152(12):2465-70. doi: 10.1001/archinte.152.12.2465.
6
[Prognostic factors of mortality during the episode of pneumonia due to Pneumocystis carinii in patients with HIV infection].
Rev Clin Esp. 2002 Aug;202(8):416-20. doi: 10.1016/s0014-2565(02)71100-4.
7
[Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].艾滋病合并肺孢子菌肺炎患者短期预后危险因素的研究
Zhonghua Yi Xue Za Zhi. 2017 Mar 21;97(11):833-837. doi: 10.3760/cma.j.issn.0376-2491.2017.11.008.
8
A Model to Predict In-Hospital Mortality in HIV/AIDS Patients with Pneumocystis Pneumonia in China: The Clinical Practice in Real World.中国 HIV/AIDS 合并卡氏肺孢子菌肺炎患者住院病死率预测模型:真实世界临床实践。
Biomed Res Int. 2019 Feb 17;2019:6057028. doi: 10.1155/2019/6057028. eCollection 2019.
9
The role of tracheostomy in acquired immunodeficiency syndrome.
Ann Thorac Surg. 1997 Oct;64(4):982-5. doi: 10.1016/s0003-4975(97)00878-3.
10
Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.获得性免疫缺陷综合征(艾滋病)患者生存率的变化:1984 - 1991年
Am J Epidemiol. 1993 Dec 1;138(11):952-64. doi: 10.1093/oxfordjournals.aje.a116815.

引用本文的文献

1
Risk factors of in-hospital mortality in patients with pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing.宏基因组二代测序诊断的卡氏肺孢子菌肺炎患者院内死亡的危险因素。
Front Cell Infect Microbiol. 2022 Sep 26;12:994175. doi: 10.3389/fcimb.2022.994175. eCollection 2022.
2
Evolutionary warning system for COVID-19 severity: Colony predation algorithm enhanced extreme learning machine.COVID-19 严重程度的进化预警系统:集群捕食算法增强型极限学习机。
Comput Biol Med. 2021 Sep;136:104698. doi: 10.1016/j.compbiomed.2021.104698. Epub 2021 Jul 30.
3
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

本文引用的文献

1
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage.采用亚段支气管肺泡灌洗术诊断获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎。
Am Rev Respir Dis. 1984 Jun;129(6):929-32. doi: 10.1164/arrd.1984.129.6.929.
2
Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia.卡氏肺孢子菌在接受卡氏肺孢子菌肺炎治疗的获得性免疫缺陷综合征患者肺组织中的持续存在情况。
Am Rev Respir Dis. 1984 Dec;130(6):1161-5. doi: 10.1164/arrd.1984.130.6.1161.
3
Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.
免疫功能低下成人卡氏肺孢子菌肺炎的临床经过、治疗和转归:17 年回顾性分析。
Crit Care. 2018 Nov 19;22(1):307. doi: 10.1186/s13054-018-2221-8.
4
Hematological and biochemical factors predicting SARS fatality in Taiwan.台湾地区严重急性呼吸综合征(SARS)死亡的血液学和生化预测因素
J Formos Med Assoc. 2006 Jun;105(6):439-50. doi: 10.1016/S0929-6646(09)60183-2.
卡氏肺孢子虫肺炎:获得性免疫缺陷综合征患者与其他免疫缺陷患者的比较。
Ann Intern Med. 1984 May;100(5):663-71. doi: 10.7326/0003-4819-100-5-663.
4
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者对甲氧苄啶-磺胺甲恶唑的不良反应。
Ann Intern Med. 1984 Apr;100(4):495-9. doi: 10.7326/0003-4819-100-4-495.
5
Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization.
Am Rev Respir Dis. 1986 Nov;134(5):891-6. doi: 10.1164/arrd.1986.134.5.891.
6
Confidence intervals for reporting results of clinical trials.临床试验结果报告的置信区间。
Ann Intern Med. 1986 Sep;105(3):429-35. doi: 10.7326/0003-4819-105-3-429.
7
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.甲氧苄啶-磺胺甲恶唑或喷他脒治疗获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎。一项前瞻性随机试验。
Ann Intern Med. 1986 Jul;105(1):37-44. doi: 10.7326/0003-4819-105-1-37.
8
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.获得性免疫缺陷综合征合并卡氏肺孢子虫肺炎患者的预后因素及预期寿命
Am Rev Respir Dis. 1987 Nov;136(5):1199-206. doi: 10.1164/ajrccm/136.5.1199.
9
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.叠氮胸苷(AZT)治疗艾滋病及艾滋病相关综合征患者的疗效。一项双盲、安慰剂对照试验。
N Engl J Med. 1987 Jul 23;317(4):185-91. doi: 10.1056/NEJM198707233170401.
10
Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation.
Am Rev Respir Dis. 1988 Jun;137(6):1264-7. doi: 10.1164/ajrccm/137.6.1264.